These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1967408)

  • 1. Xamoterol and the failing heart.
    Davies MK
    Lancet; 1990 Jan; 335(8681):117-8. PubMed ID: 1967408
    [No Abstract]   [Full Text] [Related]  

  • 2. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
    van Mechelen H; Ries A; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
    Timewell RM; Stark RD; Marlow HF
    Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term xamoterol in idiopathic dilated cardiomyopathy.
    Watanabe K; Hirokawa Y; Suzuki K; Masani F; Otsuka H; Shibata A
    Jpn Circ J; 1992 Jan; 56(1):12-20. PubMed ID: 1347090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.
    Cheron P; Nannan M; Pouleur H; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():46-7. PubMed ID: 1971589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient-powered treadmill--a simple alternative means of assessing heart failure and treatment in family practice.
    Tweed JA; Causer MS; Gostick NK; Jones BP; Korlipara K; Mayhew SR; Saul PA; Wright FW
    Eur Heart J; 1990 Apr; 11 Suppl A():65-6. PubMed ID: 1971597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
    de Feyter PJ; Serruys PW; Suryapranata H
    Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the autonomic control of the failing heart.
    Snow HM
    Basic Res Cardiol; 1989; 84 Suppl 1():163-76. PubMed ID: 2573339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure.
    Sorensen EV; Faergeman O; Day M; Bastain W
    Eur J Clin Pharmacol; 1988; 35(2):183-5. PubMed ID: 2903827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine changes post myocardial infarction: effects of xamoterol.
    McMurray JJ; Lang CC; MacLean D; McDevitt DG; Struthers AD
    Am Heart J; 1990 Jul; 120(1):56-62. PubMed ID: 1972861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
    Mehlsen J; Trap-Jensen J
    Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xamoterol and the failing heart.
    Böhm M; Mittmann C; Schwinger R; Erdmann E
    Lancet; 1989 Nov; 2(8673):1213-4. PubMed ID: 2572917
    [No Abstract]   [Full Text] [Related]  

  • 17. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
    Marlow HF
    Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
    Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
    Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.